Pushkal Garg, CMO & EVP Development & Med Affairs at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 7,128 shares at $198.03 ($1.4M) on 2023-04-28, disclosed to the SEC on 2023-04-28.
Open-market sale of $1.4M ALNY by CMO & EVP Development & Med Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $193.18 | 151 | $29K | 2.1% |
| 2 | $193.93 | 700 | $136K | 9.6% |
| 3 | $194.94 | 779 | $152K | 10.8% |
| 4 | $194.94 | 779 | $152K | 10.8% |
| 5 | $195.65 | 80 | $16K | 1.1% |
| 6 | $197.08 | 129 |
| $25K |
| 1.8% |
| 7 | $195.46 | 204 | $40K | 2.8% |
| 8 | $196.62 | 103 | $20K | 1.4% |
| 9 | $198.03 | 715 | $142K | 10.1% |
| 10 | $198.03 | 715 | $142K | 10.1% |
| 11 | $199.54 | 385 | $77K | 5.5% |
| 12 | $199.54 | 385 | $77K | 5.5% |
| 13 | $200.35 | 955 | $191K | 13.6% |
| 14 | $200.35 | 955 | $191K | 13.6% |
| 15 | $201.30 | 93 | $19K | 1.3% |
| Total | $197.54 avg | 7,128 | $1.4M | 100% |
| Filing → |
| ALNY | SELL | 2026-03-02 | $1.5M | — | Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |